Skip to page content  Home  Recombinant DNA  Genetics, Health, and Society  Dual Use Research  Clinical Research Policy
  About NSABB
  News and Events
  Meetings
  FAQs
  NSABB Documents
  Participating Agencies
  Educational Materials
  DUR-Related USG Activities and Materials
 
NSABB - Past Meetings
  2012  
   November 27  
   March 29-30  
  2011  
   December 15  
   June 23  
   January 5 (Public Consultation on Culture of Responsibility)  
  2010  
   October 19  
  2009  
   December 3  
   May 27 (Teleconference)  
   April 29  
   April 3 (Public Consultation on Personnel Reliability)  
  2008  
   December 10  
   February 27-28  
  2007  
   October 11 (NSABB-RAC Roundtable on Synthetic Biology)  
   April 19  
   January 31 (National Security Briefing - Closed Session)  
  2006  
   October 25  
   July 13  
   March 30  
  2005  
   November 21  
   September 29 (Review of Confidential Information - Closed Session)  
   June 30 - July 1  
 

November 27, 2012  
   Agenda   
   Webcast    
  Meeting Materials:  
  "Dual Use Research of Concern: The March 29 Policy"
Franca R. Jones, Ph.D., Assistant Director - Chemical and Biological Countermeasures, Office of Science and Technology Policy, Executive Office of the President
   USG Policy for Oversight of Life Sciences Dual Use Research of Concern   
 
  "Attributes of Highly Pathogenic Avian Influenza H5N1 Research that May Warrant Alternative Venues or Modes of Communication"
Kenneth I. Berns, M.D., Ph.D., Co-Chair, NSABB Working Group on Global Engagement, and Director of Genetics Institute (Retired), University of Florida, Gainesville, FL
   Draft NSABB Report on Global Engagement   
 
  "A Proposed Framework for Guiding HHS Funding Decisions about Highly Pathogenic Avian Influenza H5N1 Gain-of-Function Research"
Amy P. Patterson, M.D., Associate Director for Science Policy, National Institutes of Health
 

March 29-30, 2012  
   Full Recommendations   
   NSABB Statement    

December 15, 2011 via teleconference  
   Agenda   
   Federal Register Notice   
  Presentation Materials:  
   Draft Report of the Codes of Conduct (Tab 3A)   
   Codes of Conduct Tool Kit (Tab 3B)   
   Dual Use Educational Module (Tab 3C)   
   Codes of Conduct Presentation (Tab 3D)   
   International Engagement Update (Tab 4)    
 

June 23, 2011 Meeting  
   Agenda   
   Webcast   
   Minutes   
  Presentation Materials  
  "Federal Experts Security Advisory Panel (FESAP): Recommendations Concerning the Select Agent Program"
Laura A. Kwinn, Ph.D., Science Policy Advisor, Office of Policy and Planning
Office of the Assistant Secretary for Preparedness and Response
U.S. Dept. of Health and Human Services
 
  "Federal Experts Security Advisory Panel Recommendations and Future Activities"
Laura A. Kwinn, Ph.D., Science Policy Advisor, Office of Policy and Planning
Office of the Assistant Secretary for Preparedness and Response
U.S. Dept. of Health and Human Services
 
  "NSABB Working Group on Culture of Responsibility"
Paul S. Keim, Ph.D., Acting Chair, NSABB and Co-Chair, NSABB Working Group on Culture of Responsibility;
and, Division Director, Pathogen Genomics, The Translational Genomics Research Institute,
Cowden Endowed Chair in Microbiology, Northern Arizona University;

 
  "Selected Recommendations on Personnel Responsibility"
Susan Ehrlich, J. D., LL.M., Member, NSABB Working Group on Culture of Responsibility
 
   Draft report   
  "NSABB Working Group on Outreach and Education"
Christine M. Grant, J.D., Co-Chair, NSABB Working Group on Outreach and Education, and CEO/Founder,
InfecDetect Rapid Diagnostic Tests, Princeton, NJ

Michael Imperiale, Ph.D., Co-Chair, NSABB Working Group on Outreach and Education, and Professor,
Department of Microbiology and Immunology, University of Michigan
 
   The draft report discussed has since been finalized and posted to the NSABB Documents page.  
  "NSABB Working Group on Journal Review Policies"
Arturo Casadevall, M.D., Co-Chair, NSABB Working Group on Journal Review Policies, and Professor and Chairman,
Department of Microbiology and Immunology, Albert Einstein School of Medicine

Jeffery F. Miller, Ph.D., Co-Chair, NSABB Working Group on Journal Review Policies,
and Professor and Chair, Department of Microbiology, Immunology and Molecular Genetics,
David Geffen School of Medicine, University of California - Los Angeles
 
  "NSABB Working Group on Codes of Conduct"
Kenneth I. Berns, M.D., Ph.D., Co-Chair, NSABB Working Group on Codes of Conduct,
and Director of Genetics Institute, University of Florida
 
  "NSABB Working Group on International Engagement"
David R. Franz, D.V.M., Ph.D., Co-Chair, NSABB Working Group on International Engagement,
and Vice President and Chief Biological Scientist, Midwest Research Institute
 

January 5, 2011 Meeting  
   Agenda   
   Webcast  
  Presentation Materials  
  PANEL 1: Engaged institutional leadership: Promoting biosecurity, personnel reliability, and a culture of responsibility  
   Richard B. Marchase, Ph.D.
Vice President for Research and Economic Development; The University of Alabama at Birmingham
 
   Stanley Maloy, Ph.D.
Professor and Dean, College of Sciences; San Diego State University
 
   Ronald Atlas, Ph.D.
Professor of Art and Sciences Biology; University of Louisville
 
   Bruce Whitney, Ph.D.
Associate Vice President for Research Compliance, Responsible Official, and Biological Safety Officer; Texas A&M University
 
  PANEL 2: Encouraging biosecurity awareness and promoting responsible conduct in the laboratory through communication, lab rapport, and a strong sense of team  
   Jean L. Patterson, Ph.D.
Chair, Department of Virology and Immunology; Southwest Foundation for Biomedical Research
 
   Theresa M. Koehler, Ph.D.
Microbiology and Molecular Genetics, Herbert L. and Margaret W. DuPont Professorship in Biomedical Science; University of Texas - Houston Health Science Center
 
   Jenni N. Weeks, Ph.D.
Postdoctoral Researcher; St. Jude Children's Research Hospital; Texas A&M University
 
   William S. Mellon, Ph.D.
Professor of Pharmaceutical Sciences and Associate Dean for Research Policy; University of Wisconsin
 
   Deborah E. Wilson, Dr.P.H., C.B.S.P.
Director, Division of Occupational Health and Safety; National Institutes of Health
 
  PANEL 3: Peer reporting of concerning behaviors  
   William Gaylord, III
Director, R&D; Environmental Health & Safety and Responsible Official; Allergan Sales, LLC
 
   Paul B. Kimsey, Ph.D.
Deputy Director and Responsible Official; California State Public Health Laboratory
 
   Theodoro Ross, M.D., Ph.D.
Comprehensive Cancer Center Hematology; University of Michigan
 
   Thomas Pistole, Ph.D.
Professor of Microbiology; University of New Hampshire
 
   Jenni N. Weeks, Ph.D.
Postdoctoral Researcher; St. Jude Children's Research Hospital; Texas A&M University
 
   Stephanie Quincy, J.D.
Partner; Steptoe & Johnson, LLP, Phoenix, AZ
 
  PANEL 4: Addressing impediments to disclosure of negative information about job candidates  
   Karen B. Silverberg
Associate Dean for Human Resources & Faculty APT; Duke University School of Medicine
 
   Stephanie Quincy, J.D.
Partner; Steptoe & Johnson, LLP, Phoenix, AZ
 
   Samuel I. Miller, MD
Director, Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; University of Washington
 
   Olaf Schneewind, M.D., Ph.D.
Director, Great Lakes Regional Center of Excellence for Biodefense and Emerging Infectious Diseases; University of Chicago
 
  PANEL 5: Assessment of effectiveness and impact of practices for strengthening personnel reliability and culture of responsibility  
   Susan E. Cozzens, Ph.D.
Director, Technology Policy and Assessment Center (TPAC)
Georgia Institute of Technology
 
   Mark S. Frankel, Ph.D.
Director, Scientific Freedom, Responsibility and Law Program; American Association for the Advancement of Science
 
   Janet Peterson, R.B.P., C.B.S.P.
Biosafety Officer and Assistant Director, Department of Environmental Safety; University of Maryland
 
 

October 19, 2010 Meeting  
   Agenda   
   Webcast  
   Minutes   
  Presentation Materials  
   "Impetus for Report from National Research Council"
Mary E. Groesch, Ph.D., Senior Advisor for Science Policy, Office of Biotechnology Activities, Office of Science Policy, National Institutes of Health
 
   "Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA"
Jessica M. Tucker, Ph.D. (Contractor), Supporting the U.S. Department of Health and Human Services
 
   "NIH Guidelines to Address Synthetic Nucleic Acids"
Jacqueline Corrigan-Curay, J.D., M.D., Executive Secretary, NIH Recombinant DNA Advisory Committee, Acting Director, Office of Biotechnology Activities, National Institutes of Health
 
   "US Government Deliberation on Dual Use Research Oversight:Status Update"
Mary E. Groesch, Ph.D., Senior Advisor for Science Policy, Office of Biotechnology Activities, Office of Science Policy, National Institutes of Health
 
   "Overview of Executive Order on Optimizing the Security of Biological Select Agents and Toxins in the United States"
Mary E. Groesch, Ph.D., Senior Advisor for Science Policy, Office of Biotechnology Activities, Office of Science Policy, National Institutes of Health
 
   "Considerations of Advances in Synthetic Biology in Relation to the NSABB Report 'Addressing Biosecurity Concerns Related to Synthetic Biology': (1) Emerging Scientific Advances and (2) Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome"
David A. Relman, M.D., Chair, NSABB Working Group on Synthetic Biology, and
Professor of Microbiology and Immunology and of Medicine, Stanford University
 
   "NSABB Working Group on Culture of Responsibility"
Paul S. Keim, Ph.D., Acting Chair, NSABB and Co-Chair, NSABB Working Group on Culture of Responsibility, and
Division Director, Pathogen Genomics, The Translational Genomics Research Institute,
Cowden Endowed Chair in Microbiology, Northern Arizona University

Stanley M. Lemon, M.D., Co-Chair, NSABB Working Group on Culture of Responsibility, and
Professor, Division of Infectious Diseases, UNC School of Medicine
 
   "NSABB Working Group on International Engagement"
Stuart Levy, M.D., Co-Chair, NSABB Working Group on International Engagement, and
Director, Center for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine
 
   "NSABB Working Group on Outreach and Education"
Michael Imperiale, Ph.D., Co-Chair, NSABB Working Group on Outreach and Education, and
Professor, Department of Microbiology and Immunology, University of Michigan

Christine M. Grant, J.D., Co-Chair, NSABB Working Group on Outreach and Education, and
CEO/Founder, InfecDetect Rapid Diagnostic Tests, LLC, Princeton, NJ
 
   "NSABB Working Group on Journal Review Policies"
Arturo Casadevall, M.D., Co-Chair, NSABB Working Group on Journal Review Policies, and
Professor and Chairman, Department of Microbiology and Immunology, Albert Einstein School of Medicine

Jeffery F. Miller, Ph.D., Co-Chair, NSABB Working Group on Journal Review Policies, and
Professor and Chair, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California - Los Angeles
 
   "NSABB Working Group on Codes of Conduct"
Kenneth I. Berns, M.D., Ph.D., Co-Chair, NSABB Working Group on Codes of Conduct, and
Director of Genetics Institute, University of Florida

Andrew A. Sorensen, Ph.D., M.P.H., Co-Chair, NSABB Working Group on Codes of Conduct, and
Senior Vice President for Development, Special Assistant to the President for Advancement, President of the Ohio State University Foundation, The Ohio State University
 

December 3, 2009 Meeting  
   Agenda   
   Webcast  
   Minutes  
  Presentation Materials  
   "New Tasks for the NSABB"
Gerald Parker, D.V. M., Ph.D., M.S., Principal Deputy Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
 
   "USG Policy Actions on Biosecurity"
Diane DiEuliis, Ph.D., Office of Science and Technology Policy, Executive Office of the President
 
   "Applicability of the Select Agent Regulations to Issues of Synthetic Genomics"
Tru Twedt, D.V.M., C.B.S.P., Associate Director for Science, Division of Select Agents and Toxins, Centers for Disease Control and Prevention
 
   "Screening Framework Guidance for Synthetic Guidance for Synthetic Double-Stranded DNA Providers"
Jessica Tucker, Ph.D., AAAS Science and Technology Policy Fellow, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
 
   Federal Register Notice: "Screening Framework Guidance for Synthetic Double-Stranded DNA Providers"   
   "NIH Guidelines for Research Involving Recombinant DNA - Biosafety and Synthetic Nucleic Acids"
Jacqueline Corrigan-Curay, J.D., M.D., Executive Secretary, NIH Recombinant DNA Advisory Committee, Acting Director, Office of Biotechnology Activities, National Institutes of Health
 
   "Addressing Biosecurity Concerns Related to Synthetic Biology"
David Relman, M.D., Chair, NSABB Working Group on Synthetic Biology, and Professor of Microbiology and Immunology and of Medicine, Stanford University
 
   Draft Report on "Addressing Biosecurity Concerns Related to Synthetic Biology"   
   "Update from the Working Group on Outreach and Education"
Michael Imperiale, Ph.D., Chair, NSABB Working Group on Outreach and Education, and Professor, Department of Microbiology and Immunology, University of Michigan Medical School
 
   "NSABB Working Group on International Engagement"
Stuart Levy, M.D., Co-Chair, NSABB Working Group on International Engagement, and Director, Center for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine
 
 

May 27, 2009 Teleconference  
   NSABB Teleconference to finalize the NSABB report, Enhancing Personnel Reliability Among Individuals with Access to Select Agents  
   Agenda   
   Draft Report  This draft includes proposed changes to the report that were discussed and the April 29, 2009 NSABB meeting. New text has been highlighted.  
 

April 29, 2009 Meeting  
  Agenda and Webcasts  
   Agenda   
   Draft Report   
   Webcast  
   Minutes   
Presentation Materials  
   NSABB Working Group on Personnel Reliability: Overview of Deliberations and Draft Report on Personnel Reliability
Paul Keim, Ph.D.
NSABB Member and Regents Professor of Biology, Northern Arizona University
 
   Public Consultation on Personnel Reliability
Michael Imperiale, Ph.D.
NSABB Member and Professor, University of Michigan Medical School
 
   NSABB Draft Report: Enhancing Personnel Reliability Among Individuals with Access to Select Agents
Paul Keim, Ph.D.
 
 

April 3, 2009 Public Consultation on Personnel Reliability  
  Agenda and Webcasts  
   Agenda   
   Webcast/Podcast  
Presentation Materials  
  Background and Introduction to the Personnel Reliability Issue  
   Understanding and Improving Laboratory Security, Personnel Reliability, and Safety
Diane DiEuliis, Ph.D.
Office of Science and Technology Policy
 
  Panel I - Extant Models of Personnel Reliability Programs  
   The Army Biological Personnel Reliability Program (BPRP)
John Humpton
Combatting WMD and Proliferation Policy Division G-3/5/7, Headquarters, Department of the Army
 
   LLNL Select Agent Human Reliability Program
Eric Gard, Ph.D.
Global Security Directorate, Lawrence Livermore National Laboratory
 
   Bioterrorism Risk Assessment Group
John Stovers
Bioterrorism Risk Assessments, Criminal Justice Information Services, FBI
 
   NSABB Briefing: Security Risk Assessments for Possession, Use, and Transfer of Select Agent
Robbin Weyant, Ph.D.
Director, Division of Select Agents and Toxins, Coordinating Office for Terrorism Preparedness and Emergency Response, CDC
 
   Managing Personnel Reliability at the Galveston National Laborator
Stan Lemon, M.D.
NSABB Member and Director, Institute for Human Infections and Immunity and Professor, Departments of Microbiology & Immunology and Internal Medicine, University of Texas Medical Branch/Galveston National Laboratory
 
  Presentation - Optimal Personnel Characteristics  
   NSABB Working Group on Personnel Reliability: Optimal Personnel Characteristics
Dennis Kasper, M.D.
NSABB Chair and Chair of the Working Group on Personnel Reliability
 
  Panel II - Optimal Personnel Characteristics: Scientific and Professional Integrity and Compliance with Biosafety and Biosecurity Standards  
   Dennis Metzger, Ph.D.
Professor and Theobald Smith Endowed Chair, and Director, Center for Immunology and Microbial Disease, Albany Medical College
 
   John Dahlberg, Ph.D.
Director, Division of Investigative Oversight, HHS Office of Research Integrity
 
   Researcher Compliance with Biosafety
Debra Hunt, Dr.P.H.
Director, Biological Safety, Duke University
 
   Education About the Responsible Conduct of Research
Nicholas Steneck, Ph.D.
Director, Research Ethics and Integrity Program, University of Michigan Institute for Clinical and Health Research & Professor Emeritus of History, University of Michigan
 
   Select Agent Research: Considerations for "Optimal Personnel Characteristics"
Brian Herman, Ph.D.
Vice President for Research and Professor, Cellular and Structural Biology, University of Texas Health Science Center
 
   Biosecurity and Biomedical Research: How Can We Succeed in Both?
Eric Utt, Ph.D.
Director, Worldwide Public Affairs and Policy, Pfizer Inc.
 
  Panel III - Optimal Personnel Characteristics: Emotionally Stable and Capable of Sound Judgment; Free of Vulnerability to Coercion  
   Biosurety - An Investigator's perspective
Fred Sparling, M.D.
Director, Southeast Regional Center for Excellence in Emerging Infections and Biodefense (SERCEB)
 
   Psychological Assessment in the Selection of Personnel for Specialized Roles in Government: Where does it fit in? What Role Might it Play?
C. Andy Morgan, M.D.
Associate Professor, Department of Psychiatry, Yale University
 
   Psychological Assessment
Jeff Baker, Ph.D., ABPP
Professor, Division of Rehabilitation Sciences and Chief Psychologist, Aviation Medicine, Anesthesiology, Orthopedic Surgery, University of Texas Medical Branch
 
   A system of Layered Accountability
Amy Smithson, Ph.D.
Senior Fellow, James Martin Center for Nonproliferation Studies
 

Top of Page
 

December 10, 2008 Meeting  
  Agenda and Webcasts  
   Agenda   
   Minutes   
   Webcast   
Presentation Materials  
  NSABB Personnel Reliability Working Group: Introduction to the Issue and Charge to the Working Group  
   Personnel Reliability: Introduction and Charge to NSABB
Amy Patterson, M.D.
Executive Director, NSABB
 
  Panel on Extant Personnel Reliability Programs  
   Security Risk Assessments for Possession, Use, and Transfer of Select Agents
Robbin Weyant, Ph.D.
Director, Division of Select Agents and Toxins, Coordinating Office for Terrorism Preparedness and Emergency Response, CDC
 
   Overview of DoD Biological Select Agent and Toxin (BSAT) Policies
Kenneth Cole, Ph.D.
Deputy and Medical Director, Office of the Special Assistant for Chemical and Biological Defense & Chemical Demilitarization Programs
 
   Department of Energy Biological Personnel Reliability
Terry Creque, Ph.D.
Biological Programs and Acting S&T Division, Director, Office of Intelligence and Counterintelligence, DOE
 
   LLNL Select Agent Human Reliability Program
Eric Gard, Ph.D.
Lawrence Livermore National Laboratory, Select Agent Manager
 
  Personnel Reliability Working Group: Preliminary Findings and Recommendations  
   NSABB Working Group on Personnel Reliability: Preliminary Findings and Recommendations
Dennis L. Kasper, M.D.
NSABB Chair, Harvard Medical School
 
  NSABB Working Group on Outreach and Education: Presentation and Discussion of Outreach and Education Plan  
   Strategic Plan for Outreach and Education on Dual Use Research Issues
Michael Imperiale, Ph.D.
NSABB Outreach and Education Working Group Chair, University of Michigan
 
  Update: Federal Response to NSABB Reports on Synthetic Genomics and Oversight Framework for Dual Use Research  
   U.S. Government Public Consultation Meeting on the NSABB's Proposed Oversight Framework: A Summary
Mary Mazanec, M.D., J.D.
Director, Office of Medicine, Science and Public Health, Office of the Assistant Secretary for Preparedness and Response, HHS
 
   Implementation of Synthetic DNA and Security Policy Actions
Diane C. DiEuliis, Ph.D.
Assistant Director, Life Sciences, Assistant Director, Social and Behavioral Sciences, Office of Science and Technology Policy, Executive Office of the President
 
  Highlights of the Third International Roundtable: "Sustaining Progress in the Life Sciences: Strategies for Managing Dual Use Research of Concern"  
   Update from the NSABB Working Group on International Engagement 3rd International Roundtable
David R. Franz, DVM, Ph.D.
NSABB International Working Group Co-Chair, Midwest Research Institute
 

Top of Page
 

February 27-28, 2008 Meeting  
  Agenda and Webcasts  
   Agenda   
   Minutes   
   Webcast Day 1   
   Webcast Day 2   
  Presentation Materials  
   Updates on International Engagement on Dual Use Research
David R. Franz, D.V.M., Ph.D.
NSABB International Engagement Working Group Co-Chair and Midwest Research Institute
Stuart Levy, M.D.
NSABB International Engagement Working Group Co-Chair, and Tufts University School of Medicine
 
   Consideration of NSABB Recommendations in the Development of Federal Policy on Dual Use Life Sciences Research
Ken Staley, M.D., M.P.A

Director for Biodefense Policy, Homeland Security Council, The White House
 
   Biosafety Implications of Synthetic Genomics Technology: US Policy Development
Jacqueline Corrigan-Curay, M.D., J.D.
Executive Secretary, Recombinant DNA Advisory Committee, Office of Biotechnology Activities, NIH
 
   Assessing Biosecurity Concerns Related to Synthetic Biology
David Relman, M.D.
NSABB Synthetic Genomics Working Group Chair and Stanford University School of Medicine
 
   WHO Project: Life Science Research and Development (R&D) for Global Health Security
Ottorino Cosivi, D.V.M.

Project Leader, Program for Deliberate Epidemics, World Health Organization, Geneva, Switzerland
 
   Review of the Charge of the Working Group on Outreach and Education
Michael Imperiale, Ph.D.

NSABB Working Group on Outreach and Education Chair and University of Michigan Medical School
 
   Outreach and Education Activities on Dual Use Research: Keeping the Community Apprised of Developing Federal Policies
Allan Shipp
Director of Outreach, NIH Office of Biotechnology Activities
 
  Selected Perspectives from the Research Community Regarding Outreach on Dual Use Research  
   American Bar Association - Science and Technology Law
Gilbert Whittemore, Esq.,
Chair, Section of Science & Technology Law and Counsel, Rath, Young and Pignatelli, P.C.
 
   American Biological Safety Association - Biosafety community
Janet S. Peterson, R.B.P., C.B.S.P., Assistant Director & Biosafety Officer, UM Department of Environmental Safety
 
   American Phytopathological Society - Botanists
Ray Martyn, Ph.D., APS President and Professor, Department of Botany and Plant Pathology, Purdue University
 
   American Society for Microbiology - Microbiologists
Ronald Atlas, Ph.D., Professor of Biology, University of Kentucky
 
   Association of American Medical Colleges - Medical schools and teaching hospital leadership
Stephen Heinig, Senior Policy Fellow, AAMC
 
   Association of American Universities - Research intensive universities
Patrick White,
Vice President of Federal Relations, AAU
 
   Federation of American Societies for Experimental Biology - Biological scientists at large
Carrie Wolinetz, Ph.D., Director of Communications
 
   National Association of State Universities and Land Grant Colleges - State schools, including schools of agriculture
Bruce McPheron, Ph.D., Associate Dean for Research and Graduate Education and Director of the Pennsylvania Agricultural Experiment Station at Pennsylvania State University
 
  Effective Educational Tools and Vehicles for Information Dissemination: Perspectives and Experience from the Private Sector  
   Making a Compelling Case about Dual Use Research to the Scientific Community at Large
Mark S. Frankel, Ph.D., Director, Scientific Freedom Responsibility and Law Program, American Association for the Advancement of Science
 
   SERCEB Experience in Educating the Investigator Community about Dual Use Research
Robert Cook-Deegan, M.D., Principal Investigator, Policy, Ethics, and Law Core, Southeast Regional, Center for Excellence for Emerging Infections and Biodefense (SERCEB)
 
   FAS Educational Efforts Related to Dual Use Research: Web-Based Tools, Case Studies, and More
Michael Stebbins, Ph.D., Director of Biology Policy, Federation of American Scientists (FAS)
 
  Final Conclusions, Closing Remarks and Adjournment
Michael Imperiale, Ph.D.
Chair, NSABB Working Group on Outreach and Education Chair and University of Michigan Medical School
Dennis L. Kasper, M.D.
NSABB Chair and Harvard Medical School
 
 

October 11, 2007 (NSABB-RAC Roundtable on Synthetic Biology)  
  Agenda and Meeting Summary  
   Agenda   
   Meeting Summary   
 

April 19, 2007 Meeting  
  Agenda, Minutes, and Webcast  
   Agenda   
   Minutes   
   Webcast   
  Presentation Materials  
   DRAFT Report of the NSABB Working Group on Oversight Framework Development   

Top of Page
 

January 31, 2007 Meeting (National Security Briefing - Closed Session)  
   Federal Register Notice   

Top of Page
 

October 25, 2006 Meeting  
  Agenda, Minutes, and Webcast  
   Agenda   
   Webcast   
  Presentation Materials  
   NSABB Working Group on Synthetic Genomics   
   Conceptualizing an Oversight Framework for Dual Use Research   
   Addressing Biosecurity concerns Related to the Synthesis of Select Agents   

Top of Page
 

July 13, 2006 Meeting  
  Agenda, Minutes, and Webcast  
   Agenda   
   Minutes   
   Webcast   
  Presentation Materials  
   NSABB Draft Guidance Documents   
   Introduction and Dual Use Criteria Working Group    
   Communications Working Group   
   Codes of Conduct Working Group   
   International Collaboration Working Group   
   Synthetic Genomics Working Group   
   Next Steps   

Top of Page
 

March 30, 2006 Meeting  
  Agenda, Minutes, and Webcast  
   Agenda   
   Minutes   
   Webcast   
  Presentation Materials  
   Dual Use Criteria Working Group   
   Codes of Conduct Working Group   
   Synthetic Genomics Working Group   
   Communications Working Group   
   Presentation on NRC Report, "Globalization, Biosecurity and the Future of the Life Sciences"   
   "Overview of Global Perceptions and Priorities"   
   "Raising Awareness in the Global Research Community: Challenges and Benefits"   
   "The Dual Use Dilemma: Perspectives of a Non-Government Organization"   

Top of Page
 

November 21, 2005 Meeting  
  Agenda, Minutes, and Webcast  
   Agenda   
   Minutes   
   Webcast   
  Presentation Materials  
   Criteria for Identifying Dual Use Research and Results    
   Codes of Conduct Progress Report   
   Communication of Dual Use Research Results, Methods, and Technologies    
   International Progress Report   

Top of Page
 

September 29, 2005 Teleconference (Review of Confidential Information - Closed Session)  
   Federal Register Notice   

Top of Page
 

June 30 - July 1, 2005 Meeting  
  Agenda, Minutes, Webcasts, and Transcripts  
   Agenda   
   Minutes   
   Transcript Day 1   
   Transcript Day 2   
   Webcast June 30th part 1   
   Webcast June 30th part 2   
   Webcast June 30th part 3   
   Webcast June 30th part 4   
   Webcast July 1st part 1   
   Webcast July 1st part 2   
  Presentation Materials  
   Dual-use results and scientific journals   
   Microbes as Weapons: Is There a Line In The Sand?    
   Risks and Rewards of Synthetic Biology    
   Balancing Biosecurity& Scientific Progress: The Need for a Culture of Responsibility    
   National Science Advisory Board for Biosecurity: Purpose, Structure, and Operations    
   Regulation of DNA Synthesis    
   Past as Prologue: Are there Lessons to be Learned from the Nuclear Physics and Cryptography Communities?    
   Challenges in Proposing a Code of Conduct with Dual-Use Perspectives    
   Dual-Use Information: Issues For NSABB    
   Communication of Dual Communication of Dual-Use Research Use Research Results Methods and Technologies Results Methods and Technologies    
   NSABB Inaugural Meeting: Opening Remarks    

Top of Page
 
 
none
Disclaimer | Privacy Policy | FOIA | Accessibility | Directions to OBA
none
HHS - Home Page Department of Health and Human Services   National Institutes of Health - Home Page National Institutes of Health   N I H - Office of Science Policy Office of Science Policy   USA.gov - government made easy
none
N I H - Office of Biotechnology Activities N I H - Office of Science Policy National Institutes of Health, DHHS